KEYNOTE-630: Randomizing Patients To Get Either Pembrolizumab Or Placebo

Jessica Geiger MD Of The Cleveland Clinic Discusses KEYNOTE-630: Randomizing Patients To Get Either Pembrolizumab Or Placebo.